23,283 Shares in Nanobiotix S.A. (NASDAQ:NBTX) Bought by Jane Street Group LLC

Jane Street Group LLC purchased a new position in shares of Nanobiotix S.A. (NASDAQ:NBTX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 23,283 shares of the company’s stock, valued at approximately $73,000.

Separately, Geode Capital Management LLC acquired a new position in shares of Nanobiotix during the 4th quarter worth about $29,000. 38.81% of the stock is owned by institutional investors.

Nanobiotix Stock Up 2.6%

Shares of Nanobiotix stock opened at $4.71 on Monday. The business has a fifty day simple moving average of $3.57 and a two-hundred day simple moving average of $3.44. Nanobiotix S.A. has a 1 year low of $2.76 and a 1 year high of $6.00.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. UBS Group upgraded shares of Nanobiotix to a “hold” rating in a research note on Monday, February 17th. Guggenheim dropped their price objective on Nanobiotix from $12.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, April 4th.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.